Suppr超能文献

关于国家疾病负担评估中关键方法学决策的思考

Reflections on key methodological decisions in national burden of disease assessments.

作者信息

von der Lippe Elena, Devleesschauwer Brecht, Gourley Michelle, Haagsma Juanita, Hilderink Henk, Porst Michael, Wengler Annelene, Wyper Grant, Grant Ian

机构信息

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

出版信息

Arch Public Health. 2020 Dec 31;78(1):137. doi: 10.1186/s13690-020-00519-7.

Abstract

BACKGROUND

Summary measures of population health are increasingly used in different public health reporting systems for setting priorities for health care and social service delivery and planning. Disability-adjusted life years (DALYs) are one of the most commonly used health gap summary measures in the field of public health and have become the key metric for quantifying burden of disease (BoD). BoD methodology is, however, complex and highly data demanding, requiring a substantial capacity to apply, which has led to major disparities across researchers and nations in their resources to perform themselves BoD studies and interpret the soundness of available estimates produced by the Global Burden of Disease Study.

METHODS

BoD researchers from the COST Action European Burden of Disease network reflect on the most important methodological choices to be made when estimating DALYs. The paper provides an overview of eleven methodological decisions and challenges drawing on the experiences of countries working with BoD methodology in their own national studies. Each of these steps are briefly described and, where appropriate, some examples are provided from different BoD studies across the world.

RESULTS

In this review article we have identified some of the key methodological choices and challenges that are important to understand when calculating BoD metrics. We have provided examples from different BoD studies that have developed their own strategies in data usage and implementation of statistical methods in the production of BoD estimates.

CONCLUSIONS

With the increase in national BoD studies developing their own strategies in data usage and implementation of statistical methods in the production of BoD estimates, there is a pressing need for equitable capacity building on the one hand, and harmonization of methods on the other hand. In response to these issues, several BoD networks have emerged in the European region that bring together expertise across different domains and professional backgrounds. An intensive exchange in the experience of the researchers in the different countries will enable the understanding of the methods and the interpretation of the results from the local authorities who can effectively integrate the BoD estimates in public health policies, intervention and prevention programs.

摘要

背景

人口健康的汇总指标越来越多地应用于不同的公共卫生报告系统,以确定医疗保健和社会服务提供及规划的优先事项。伤残调整生命年(DALYs)是公共卫生领域最常用的健康差距汇总指标之一,已成为量化疾病负担(BoD)的关键指标。然而,疾病负担方法复杂且对数据要求很高,需要具备相当的应用能力,这导致不同研究人员和国家在开展自身疾病负担研究及解读全球疾病负担研究得出的现有估计值的合理性方面,资源存在重大差异。

方法

来自欧洲疾病负担成本行动网络的疾病负担研究人员反思了在估计伤残调整生命年时要做出的最重要的方法选择。本文借鉴各国在本国研究中运用疾病负担方法的经验,概述了11项方法决策和挑战。对每个步骤都进行了简要描述,并在适当情况下提供了来自世界各地不同疾病负担研究的一些示例。

结果

在这篇综述文章中,我们确定了一些关键的方法选择和挑战,这些在计算疾病负担指标时很重要,需要理解。我们提供了不同疾病负担研究的示例,这些研究在疾病负担估计的产生过程中,在数据使用和统计方法实施方面制定了自己的策略。

结论

随着各国疾病负担研究在疾病负担估计的产生过程中,在数据使用和统计方法实施方面制定自己的策略,一方面迫切需要进行公平的能力建设,另一方面需要统一方法。针对这些问题,欧洲地区出现了几个疾病负担网络,这些网络汇聚了不同领域和专业背景的专业知识。不同国家研究人员之间的深入经验交流将有助于地方当局理解这些方法并解读结果,从而能够有效地将疾病负担估计纳入公共卫生政策、干预和预防计划。

相似文献

1
Reflections on key methodological decisions in national burden of disease assessments.
Arch Public Health. 2020 Dec 31;78(1):137. doi: 10.1186/s13690-020-00519-7.
2
Conducting national burden of disease studies in small countries in Europe- a feasible challenge?
Arch Public Health. 2021 May 11;79(1):73. doi: 10.1186/s13690-021-00599-z.
3
Methodological considerations in injury burden of disease studies across Europe: a systematic literature review.
BMC Public Health. 2022 Aug 17;22(1):1564. doi: 10.1186/s12889-022-13925-z.
4
Putting health metrics into practice: using the disability-adjusted life year for strategic decision making.
BMC Public Health. 2013;13 Suppl 2(Suppl 2):S2. doi: 10.1186/1471-2458-13-S2-S2. Epub 2013 Jun 17.
6
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Systematic review of foodborne burden of disease studies: quality assessment of data and methodology.
Int J Food Microbiol. 2013 Aug 16;166(1):34-47. doi: 10.1016/j.ijfoodmicro.2013.05.029. Epub 2013 Jun 13.
8
Recommendations to plan a national burden of disease study.
Arch Public Health. 2021 Jul 7;79(1):126. doi: 10.1186/s13690-021-00652-x.
10
Quantifying Burden of Disease to Measure Population Health in Korea.
J Korean Med Sci. 2016 Nov;31 Suppl 2(Suppl 2):S101-S107. doi: 10.3346/jkms.2016.31.S2.S101.

引用本文的文献

1
Estimation of Disability Adjusted Life Years in Pediatric Injury Patients at a Zonal Referral Hospital in Northern Tanzania.
Sage Open Pediatr. 2025 Aug 27;12:30502225251365185. doi: 10.1177/30502225251365185. eCollection 2025 Jan-Dec.
2
The importance of redistribution process of ill-defined deaths in national mortality database.
Arch Public Health. 2025 Jul 11;83(1):185. doi: 10.1186/s13690-025-01652-x.
4
Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses.
Front Public Health. 2025 Jun 11;13:1595159. doi: 10.3389/fpubh.2025.1595159. eCollection 2025.
5
A systematic review of the methodological considerations in Campylobacter burden of disease studies.
PLoS Negl Trop Dis. 2025 Apr 22;19(4):e0012681. doi: 10.1371/journal.pntd.0012681. eCollection 2025 Apr.
6
Burden of disease attributable to high body mass index in Belgium: a comparative risk assessment analysis.
BMJ Public Health. 2025 Jan 16;3(1):e002446. doi: 10.1136/bmjph-2024-002446. eCollection 2025 Jan.
7
Prepandemic inequalities in the burden of disease in Scotland due to multiple deprivation: a retrospective study.
BMJ Public Health. 2023 Dec 1;1(1):e000191. doi: 10.1136/bmjph-2023-000191. eCollection 2023 Nov.
8
Standardised reporting of burden of disease studies: the STROBOD statement.
Popul Health Metr. 2024 Oct 7;22(1):28. doi: 10.1186/s12963-024-00347-9.
10
Trends in tracheal, bronchial and lung cancer attributed to smoking in South America: Global Burden of Disease analysis 1990-2019.
Rev Panam Salud Publica. 2024 Apr 4;48:e30. doi: 10.26633/RPSP.2024.30. eCollection 2024.

本文引用的文献

1
Migraine and tension-type headache in Germany. Prevalence and disease severity from the BURDEN 2020 Burden of Disease Study.
J Health Monit. 2020 Sep 9;5(Suppl 6):2-24. doi: 10.25646/6990.2. eCollection 2020 Sep.
3
Dutch DALYs, current and future burden of disease in the Netherlands.
Arch Public Health. 2020 Sep 22;78:85. doi: 10.1186/s13690-020-00461-8. eCollection 2020.
4
Valuing the years of life lost due to COVID-19: the differences and pitfalls.
Int J Public Health. 2020 Jul;65(6):719-720. doi: 10.1007/s00038-020-01430-2. Epub 2020 Jul 20.
6
European burden of disease network: strengthening the collaboration.
Eur J Public Health. 2020 Feb 1;30(1):2-3. doi: 10.1093/eurpub/ckz225.
7
Assessing the quality of cause of death data in six high-income countries: Australia, Canada, Denmark, Germany, Japan and Switzerland.
Int J Public Health. 2020 Jan;65(1):17-28. doi: 10.1007/s00038-019-01325-x. Epub 2020 Jan 14.
8
Prioritising the development of severity distributions in burden of disease studies for countries in the European region.
Arch Public Health. 2020 Jan 9;78:3. doi: 10.1186/s13690-019-0385-6. eCollection 2020.
10
The Dutch Public Health Foresight Study 2018: an example of a comprehensive foresight exercise.
Eur J Public Health. 2020 Feb 1;30(1):30-35. doi: 10.1093/eurpub/ckz200.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验